HOME >> BIOLOGY >> NEWS
Epigenetic activity silences Rb2/P130 gene in lung cancer

The attaching of methyl--or chemical--groups onto DNA sequences within the tumor suppressing gene Rb2/p130 can cause the gene to cease functioning in non-small lung cancer cells (NSLC) and retinoblastoma cells, researchers at Temple University's Sbarro Institute for Cancer Research and Molecular Medicine and Italy's University of Siena have discovered.

Their findings are reported in two studies: "Tumor-specific exon 1 mutations could be the 'hit event' predisposing Rb2/p130 gene to epigenetic silencing in lung cancer" and "Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implications for pathogenesis and therapeutic approach," both of which appear in September issues of Oncogene (http://www.nature.com/onc).

The joint studies at Temple and Siena were coordinated by Antonio Giordano, M.D., Ph.D., director of Sbarro Institute at Temple (http://www.shro.org), and by Marcella Macaluso of the Sbarro Institute and Caterina Cinti of both Centro Nazionale Ricerche and the University of Siena.

Giordano said that the researchers were puzzled when they found Rb2/130, the tumor suppressing gene discovered by Giordano in the early 1990s, in an epigenetic state in both the NSLC and retinoblastoma cells. In this epigenetic state, the gene showed no signs of mutation, but is silent in its expression or function.

Further examination of the gene found that it had been methylated, a process in which methyl or chemical groups attached themselves to the gene, attacking a sequence of the Rb2/p130's DNA and thus causing it to cease functioning.

"These studies are providing very important information on how cancerous and pre-cancerous conditions can be detected by the presence of the methylated state of Rb2/p130," said Giordano. "These cancerous or pre-cancerous conditions can be treated with drugs or agents that de-methylate the R
'"/>

Contact: Preston M. Moretz
pmoretz@temple.edu
215-204-7476
Temple University
12-Sep-2005


Page: 1 2

Related biology news :

1. Epigenetic studies will provide a better understanding of disease
2. Epigenetics to shape stem cell future
3. Epigenetic drugs, promising for breast cancer treatment
4. New view of cancer: Epigenetic changes come before mutations
5. Prenatal alcohol exposure alters brain activity in the frontal-striatal areas
6. Genes activity points to more lethal subtype of AML
7. Weizmann Institute scientists develop a general control switch for protein activity
8. Slow wave activity during sleep is lower in African-Americans than Caucasians
9. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
10. Neuronal activity gives clues to working memory
11. CSHL links activity in brain synapses and developmental abnormalities with schizophrenia gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/31/2019)... ... 30, 2019 , ... Join Julie Peacock, Vice President of ... Wednesday, June 19, 2019 at 1pm EDT where she will demonstrate how role-based ... and contract research organizations (CROs) can improve collaboration, auditing, document tracking and reporting. ...
(Date:5/26/2019)... ... May 24, 2019 , ... Zolgensma (Novartis, AveXis), an AAV-delivered gene ... for clinical use in the United States by the Food and Drug Administration today. ... to treat inherited genetic disorders in the United States and the second-ever approved treatment ...
(Date:5/23/2019)... ... May 23, 2019 , ... ... development solutions for drugs, biologics and consumer health products, is to launch its ... drugs at the BIO International Convention, which takes place at the Pennsylvania Convention ...
Breaking Biology News(10 mins):
(Date:5/15/2019)... ... 2019 , ... Milton Hershey School® has named William Charles Ballough Harding ’78 ... industry, where he is changing lives by creating solutions to global healthcare challenges through ... vision of our founders – Milton and Catherine Hershey – who always hoped for ...
(Date:5/14/2019)... ... May 13, 2019 , ... Leak Detection ... for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries’ is excited to ... aims to improve LDA’s ability to communicate directly with the marketplace; serving as ...
(Date:5/8/2019)... ... 2019 , ... Standing at 16.2 hands, Atlas is on the large side for a Quarter ... barrel racing, among other activities. When loping around a corner in late 2017, Atlas ... busy horse to only being able to walk. Fortunately Atlas’ owner, Kelly, sought the ...
(Date:5/4/2019)... ... May 03, 2019 , ... More than three thousand ... Association, the scientist and ufologist Urandir Fernandes de Oliveira, last Thursday (25), during ... results of some research carried out by the association, in partnership with scientists ...
Breaking Biology Technology:
Cached News: